Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review

Colorectal neuroendocrine cancer (CRNEC) accounts for < 1% of all colorectal cancers. It presents in advanced stages and carries a risk of poor survival. CRNEC may be diagnosed incidentally on imaging or routine endoscopy. When symptomatic, it may mimic colorectal adenocarcinoma. Syncope and immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bancheno, Wouhabe Marai, Adidam, Sneha Rao, Melaku, Mekdem Abiy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302362/
https://www.ncbi.nlm.nih.gov/pubmed/35866784
http://dx.doi.org/10.1097/MD.0000000000029616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302362/
https://www.ncbi.nlm.nih.gov/pubmed/35866784
http://dx.doi.org/10.1097/MD.0000000000029616

Ejemplares similares